Glutathione (reduced glutathione, GSH)
Glutathione: What The Studies Actually Say
Your body makes it, and Japan and Italy sell it as a prescription drug for a few uses. But swallowed, it may barely get in. The skin-lightening proof is small and mixed. And IV drips have put people in hospital. Here is what the studies actually found.
Updated 22 September 2026
Before you read this
This page explains what published studies found. That is all it is. It is not medical advice, and it is not instructions for using anything. Nothing here is meant to find, treat, cure or stop any illness. The compounds discussed on this site, retatrutide included, are not approved by the FDA for use in people. Research compounds are sold for laboratory use only — not for use in humans or animals. A study tells you what happened to the people in it. It does not tell you what would happen to you. What you do with what you read here is your responsibility, so talk to a doctor first. This page is published by Ascend Vials, which sells research compounds.
Read the full guide
Confirm you have read the notice above and enter an email address. We will send you a link back to this guide, and sometimes an email when we publish a new one. You can unsubscribe any time.
Your body already makes glutathione. Nobody argues about that part.
The real question is whether taking more of it — as a pill, a drip or a shot — does anything. Here is what the research actually found. Every claim has a link. Read them yourself.
The 30-second version
- Glutathione is a tiny peptide your body makes itself, from three amino acids.
- Swallowing it may barely work. One big dose did not raise it in blood plasma. A 6-month trial did — by about a third at the higher dose — and levels fell back after stopping.
- No trial has shown that raising it makes you healthier. The positive pill studies measured lab numbers.
- Skin lightening: small, short studies with mixed results. In the only placebo-controlled drip study, the lightening was not statistically significant, and 8 of 25 women had abnormal liver tests.
- It is a prescription drug in Japan and Italy for specific medical uses. In the US it is not an FDA-approved drug. We found no country that approves it for skin lightening, anti-aging or wellness drips.
- In 2026, FDA reported at least 30 people sickened after IV glutathione made from supplement-grade powder.
- Nothing sold online has been shown to match what the studies used. No study has checked.
What it is
Glutathione is a peptide of just three amino acids: glutamate, cysteine and glycine. Your body makes it. It is in every tissue, and the liver has the most. Review, 2013
You may have heard it called the "master antioxidant." That is a slogan, not a measurement. Here is what is known: an enzyme uses glutathione to break down hydrogen peroxide and damaged fats. That turns it into a spent form, GSSG, and a second enzyme turns it back. It also helps the body deal with foreign chemicals. Review, 2013
One emergency shows why it matters. The approved antidote for an acetaminophen (Tylenol) overdose is a drug called acetylcysteine. Its FDA label says it "probably protects the liver by maintaining or restoring the glutathione levels," or by binding the harmful breakdown product. FDA label Notice what that is: a different drug that helps the body keep up its own glutathione. It is not glutathione.
Glutathione itself is sold as pills — including "liposomal," "micellar" and under-the-tongue versions — as skin products, and as IV drips and shots. Salons, spas and clinics offer the drips to lighten skin. FDA committee minutes, 2022 · FDA Philippines, 2019
Does swallowing it even work?
This is the big question, and the studies disagree.
The problem is how it is built. Only one enzyme can break glutathione's unusual bond, and it sits on the outside of certain cells. Review, 2013 In 1992, 7 healthy people swallowed a single 3 g dose. Glutathione in their plasma — the liquid part of the blood — did not rise significantly. The researchers blamed that enzyme, working in the gut and liver. Eur J Clin Pharmacol, 1992
The biggest, longest trial came later. 54 healthy adults took glutathione or a fake pill every day for six months. At 1,000 mg a day, glutathione rose 30% to 35% in blood cells and plasma, and 260% in cells from inside the cheek. A month after stopping, it was mostly back where it started. The trial measured levels and immune lab tests — not whether anyone got healthier. Eur J Nutr, 2015
A shorter trial found nothing. 40 adults took 1,000 mg a day or a fake pill for four weeks. Neither glutathione nor two markers of cell damage changed. J Altern Complement Med, 2011
The "special" forms — liposomal, under the tongue, micellar — were each tested once, in 20 people or fewer, with no fake-pill group. Each study has company ties. Eur J Clin Nutr, 2018 · Redox Biol, 2015 · Antioxidants, 2026
| People | How long | Fake-pill group? | Did glutathione go up? | |
|---|---|---|---|---|
| One 3 g dose, 1992 | 7 | One dose | No | No |
| 1,000 mg a day, 2011 | 40 | 4 weeks | Yes | No |
| 250 or 1,000 mg a day, 2015 | 54 | 6 months | Yes | Yes |
| Liposomal, 2018 | 12 | 1 month | No | Yes |
| Under the tongue, 2015 | 20 | 3 weeks per form | No | More than swallowed |
| Micellar, 2026 | 14 | One dose, then 30 days | No | More than standard |
Read the whole table. Only two of these studies had a fake-pill group, and they disagree. None of them showed that anyone got healthier.
Lighter skin: small studies, mixed results
The theory is that glutathione makes skin produce a lighter pigment, and blocks tyrosinase, the enzyme that makes pigment. But in a lab test on pigment cells, plain glutathione did not lower pigment or tyrosinase activity. Only chemically changed versions did. That is lab data, not people. Int J Mol Sci, 2016
The pill trials in people were small and short:
- 60 medical students in Bangkok, 4 weeks: beat the fake pill at only 2 of 6 skin spots measured. J Dermatolog Treat, 2012
- 60 women in Bangkok, 12 weeks: no significant difference overall. In women over 40, it beat placebo at one spot on the forearm. Clin Cosmet Investig Dermatol, 2017
- 83 adults in Indonesia, 12 weeks, glutathione in a supplement mix: no significant difference. J Clin Aesthet Dermatol, 2021
- 46 people, 8 weeks, pills plus a cream: the summary contradicts itself, so the result is unclear. Int J Dermatol, 2021
A 2025 review called glutathione pills and creams "moderately efficacious," and said the effect did not last. Int J Dermatol, 2025
The drip
A 2025 review found only one study that compared IV glutathione with a fake drip. Int J Dermatol, 2025 In it, women in Pakistan got 12 glutathione drips over six weeks. Each was matched with a woman of the same age and skin tone who got salt water. The paper does not say who got what was decided at random. J Pak Assoc Dermatol, 2016
6 of 16 women on glutathione got at least one shade lighter, against 3 of 16 on salt water. Six months later, 1 of the 16 was still lighter. Nine women on glutathione were pulled from the study: 8 for abnormal liver tests, and 1 for anaphylactic shock, a severe allergic reaction. The authors do not recommend it for skin lightening. J Pak Assoc Dermatol, 2016
The 2025 review's verdict: IV glutathione "is contraindicated due to lack of efficacy and side effects." In plain words, it should not be used. Int J Dermatol, 2025
What else it has been tested for
| Biggest study in people | Beat placebo? | |
|---|---|---|
| Nerve damage from chemo | 185 people | Smaller trials, yes. The biggest, no |
| Parkinson's | 45 people, 3 months | No |
| Cystic fibrosis | 153 people, 6 months | No |
| Fatty liver | 29 people | Never tested against placebo |
Read the whole table. The two biggest trials found no benefit.
Chemo nerve damage. Three smaller trials with cisplatin-type chemo came out in glutathione's favor. In one, 16 of 18 on placebo had nerve damage by week 15, against 4 of 24 on glutathione. J Clin Oncol, 1995 · Ann Oncol, 1997 · J Clin Oncol, 2002 Then a 185-person phase 3 trial with paclitaxel and carboplatin found no benefit. Moderate nerve damage actually showed up sooner on glutathione. Cancer, 2014 In 2020, the American Society of Clinical Oncology reconfirmed that it recommends no drug for heading off chemo nerve damage. J Clin Oncol, 2020
Parkinson's. A 9-person study with no comparison group reported a 42% drop in disability. Prog Neuropsychopharmacol Biol Psychiatry, 1996 Placebo-controlled trials of IV glutathione in 21 people and a nasal spray in 45 did not beat placebo. Mov Disord, 2009 In the nasal-spray trial, everyone improved — including the salt-water group. One person on the higher dose developed cardiomyopathy, a disease of the heart muscle. Nobody has shown glutathione caused it. J Parkinsons Dis, 2017
Cystic fibrosis. Inhaled for 6 months in 153 people, it reached the lungs, but lung function was no better than on placebo. Am J Respir Crit Care Med, 2013 Taken by mouth for 24 weeks in 58 children, it did not improve weight gain. J Pediatr Gastroenterol Nutr, 2020
Fatty liver. One 29-person study, with no comparison group, partly paid for by the maker. A liver test improved, but without a comparison group nobody can say glutathione did it. BMC Gastroenterol, 2017
What to expect
Most of the side-effect data comes from IV glutathione. In the skin-lightening drip study, all 25 women on glutathione had side effects. Nobody on salt water did. J Pak Assoc Dermatol, 2016
| Salt water | IV glutathione | |
|---|---|---|
| Warmth during the drip | 0% | 44% |
| Stomach cramps | 0% | 40% |
| Abnormal liver tests | 0% | 32% |
| A "heart sinking" feeling | 0% | 28% |
| Diarrhea | 0% | 16% |
| Tingling | 0% | 16% |
| Dizziness | 0% | 12% |
| Anaphylactic shock | 0% | 4% (1 woman) |
Contaminated drips. In August 2026, FDA said at least 30 patients had fever, chills, signs of shock or sepsis-like symptoms after IV glutathione, and some were hospitalized. The injections were made from glutathione labeled dietary-supplement grade. Two Texas pharmacies recalled theirs for high endotoxin, a toxin from bacteria. FDA, 2026 CDC counts more than 25 sick people in at least four states. One needed intensive care for shock and blood-clotting problems. CDC, 2026 It happened in 2019 too: seven patients at one clinic got sick within minutes of a glutathione drip. FDA found endotoxin up to five times the proper limit in powder labeled "Caution: Dietary Supplement." FDA, 2019
Breathing it in. In 8 people with mild asthma, inhaled glutathione narrowed the airways. Lung function fell 19%, against 1% on salt water. Am J Respir Crit Care Med, 1997
Pills. In one 12-week trial, 2 of 60 women dropped out with raised liver enzymes, which went back to normal. The paper does not say which group they were in. Clin Cosmet Investig Dermatol, 2017
Labels and regulators. Japan's injection label lists anaphylaxis as a rare serious reaction. Japanese label The Philippines' FDA warns that skin-lightening injections can harm the liver, kidneys and nerves, and may cause a severe skin reaction called Stevens-Johnson syndrome. It gives no numbers for how often. FDA Philippines, 2019
Approved in some countries — not the US
- United States: not an FDA-approved drug. In 2022, FDA proposed keeping glutathione off the list of ingredients pharmacies may use to mix their own versions. Its outside advisers voted 8 to 5 to add it anyway. FDA committee minutes, 2022 FDA has not decided. Its May 2026 list still says "under evaluation." FDA list, 2026
- Japan: a prescription drug, sold as Tathion and as generics. Product list The pills are labeled for uses such as poisoning and severe vomiting in pregnancy. Pill label The injection adds more, including chronic liver disease, eczema and melasma. The labels lean mostly on pooled tallies from older Japanese reports. We have not seen those reports, so we cannot tell you how good they were. Injection label
- Italy: prescription-only injections, under several brand names. The main ones were first approved between 1987 and 1992. AIFA database The label for one, TAD 600 mg, covers nerve damage caused by cisplatin or similar chemotherapy. Italian label
- Philippines: the injection is approved as an add-on in cisplatin chemotherapy. No injectable product is approved there for skin lightening. FDA Philippines, 2019
Japan's injection label does list melasma, a dark-patch skin condition. But we found no country that approves glutathione for skin lightening, anti-aging or "wellness" drips.
What is still unknown
- Whether raising your levels with supplements does anything for your health. The positive pill trials measured lab numbers. Eur J Nutr, 2015
- Which form works best, if any. The special-form studies are tiny and short, as the table above shows.
- Long-term skin safety. Whether shifting skin pigment raises skin-cancer risk is a theoretical worry that no study has tested. FDA Philippines, 2019
- Drips at cosmetic doses. No properly sized randomized, blinded trial has tested them. Their safety is unknown. Int J Dermatol, 2025
- Pregnancy. The labels disagree: Japan's tells doctors to weigh breastfeeding, and Italy's reports no unwanted effects. Japanese label · Italian label We found no pregnancy data for supplements or drips.
- Still running: trials in Parkinson's (trial record) and heart surgery (trial record).
What is in the bottle is not what was studied
One more thing.
Every result on this page came from the glutathione each study used, given to people enrolled in that study.
No study has ever shown that a product sold online as "glutathione" is the same thing. Not the same purity. Not the same strength. Not proof it is sterile.
Here is what that can cost. CDC says the 2026 illnesses were likely linked to endotoxin in injections made from glutathione meant for dietary supplements. CDC, 2026 The name on the label was the same. The grade was wrong for an injection.
So take every number on this page for what it is. It describes the glutathione each study used, in the people they studied. It describes nothing else.
How to check a number yourself
You are going to see more numbers about glutathione. In a reel. In a comment. On somebody's store page.
Here is how to tell a real one from a marketing one. Five questions. About ten seconds each.
1. Is there a link to a study?
A real number comes from a paper you can open. No link means it is a claim, not a result. Search the name on pubmed.gov yourself. With glutathione you will find real papers — so also check whether each one was done in people, or in cells and mice.
2. How big was it, and how long did it run?
Small studies swing. The pill trial that found no rise had 40 people for 4 weeks. The one that found a rise had 54 people for 6 months. The only placebo-controlled drip study ended with 16 women per group.
3. Was there a group that got nothing?
The fake treatment is the whole point. In the nasal-spray Parkinson's trial, everyone improved — including the people on salt water. The 9-person study that reported a 42% improvement had no such group. Without one, nobody can tell how much of the change was the glutathione.
4. Did it measure how people did, or a lab number?
More glutathione in your blood is a lab number. It is not the same as being healthier, or looking different. The pill studies that raised glutathione did not check whether anyone got better.
5. Who paid for it?
On this page, the seller of a liposomal product paid for the study of it. Four authors of the micellar study are inventors on a pending patent for that product. That does not make them wrong. It means someone else should check.
Now run those five on this page
Every number above links to the paper it came from. The study sizes and lengths are in the tables. So are the fake-pill groups. You were told which studies measured lab numbers, and which had company ties.
The claims you hear most — lighter skin from a drip, anti-aging, "wellness" — have no big, well-controlled trial behind them.
That is the whole difference: a number you can check, and a number you are asked to believe.
This page has a date on it, near the top. When new studies publish, or FDA decides, this page changes.
Read the studies yourself
- Glutathione review, 2013 — free to read
- 6-month pill trial, 2015 — the main one · 4-week pill trial, 2011 · single dose, 1992
- Liposomal, 2018 · under the tongue, 2015 · micellar, 2026
- Pigment-cell study, 2016 · skin trials: 2012, 2017, 2021, 2021
- IV skin study, 2016 · skin review, 2025
- Chemo: 1995, 1997, 2002, phase 3, 2014 · ASCO guideline, 2020
- Parkinson's: 1996, 2009, 2017
- Cystic fibrosis: 2013, 2020 · asthma, 1997 · fatty liver, 2017
- FDA alert, 2026 · CDC, 2026 · FDA alert, 2019
- FDA committee minutes, 2022 · FDA list, 2026 · acetylcysteine label
- Japan: products, pill label, injection label · Italy: AIFA, TAD label · FDA Philippines, 2019
- Trial records: Parkinson's, heart surgery
Everything above describes what studies gave to enrolled people under a doctor's or researcher's care. This is not advice, a plan, or instructions. Glutathione is not an FDA-approved drug in the US. Japan and Italy license it as a prescription drug for specific uses, and none of the approvals we found covers skin lightening. Research compounds are not for human or animal use.